Ayuda
Ir al contenido

Dialnet


Resumen de Immunohistochemical analysis of CDX2 expression in normal choroid plexus epithelium and choroid plexus tumors

Rudi Beschorner, R. Meyermann, J. Schittenhelm, Michel Mittelbronn, M. Mugler,

  • Summary. Background: The Wnt and BMP signaling pathways are involved in the morphogenesis of both gastrointestinal and choroid plexus epithelium. In the intestine, Wnt signaling represses the expression of the tumor suppressor gene CDX2 via SOX9, a transcription factor, which is also expressed in the choroid plexus. Recently, an inverse correlation between CDX2 expression and tumor grade, tumor stage and lymph node metastasis in colorectal adenocarcinomas has been reported. Besides intestinal tissues, expression of CDX2 has also been reported in various other epithelial tissues and carcinomas. To date, no data exist on expression of CDX2 in normal and neoplastic choroid plexus epithelium. Aim: To investigate CDX2 expression in normal and neoplastic choroid plexus. Materials and Methods: Paraffin-embedded samples from 60 normal choroid plexus, including 23 fetal tissue samples and from 65 choroid plexus tumors (47 choroid plexus papillomas WHO grade I, 16 atypical choroid plexus papillomas and 2 choroid plexus carcinomas WHO grade III) were examined by immunohistochemistry. Samples from normal choroid plexus were collected from 45 autopsy cases and from 15 neurosurgical specimens. Results: Normal and neoplastic choroid plexus lacked CDX2 expression. Conclusion: In our series, immunohistochemistry shows no evidence for a role of CDX2 in development or differentiation of normal choroid plexus from the 9th gestational week until adulthood. Since choroid plexus tumors reliably lack CDX2 immunoreactivity, this marker may be helpful in distinguishing cerebral metastases from CDX2-positive adenocarcinomas and choroid plexus neoplasms. Histol Histopathol 24, 1507-1514 (2009)


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus